Whilst there was also a strong trend for better glycaemic control in the carvedilol group compared to the bisoprolol group, this did not quite reach statistical significance.
← all excerpts
Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control.
1
—
—